| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5498060 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 22 Pages |
Abstract
Risk category was associated with clinically significant relapse rates after TOS alone in HPV+ oropharyngeal cancer, comparable to historical data and traditional indications for adjuvant therapy for all oropharyngeal cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
David M. MD, Ryan K. MD, Kanograt MD, Alexander MD, Michael G. MD, JoaquÃn J. MD, Matthew A. MD, Jason T. MD, David G. MD, Eric J. MD, Courtney N. BS, Qihui MD, Katharine A. MD, John N. MD, Samuel MD, MSHP, Gregory S. MD, Bert W. MD, Robert L. MD,